Imugene (ASX:IMU) Share Price and News - StockTrack

Market Cap (3-Jul) $107,205,984 (199th)	Close (30-Jun) $0.091 0 (0%)	Volume (30-Jun) 50,159,971	Shortsold (19-Jun) 392,315,164 (5.25%) (41st)
52w High $2.75	52w Low $0.340	P/E -	EPS -0.6

	Subject
	IMU IMU Ann: Issuance of Milestone Shares Under Vaxinia Acquisition
	1 (current) 2 3
	IMU IMU Ann: Change of Director's Interest Notice - LR
	IMU IMU Ann: Imugene Presents HER-Vaxx Update at ESMO World GI Congress
	IMU IMU Ann: FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Proposed issue of securities - IMU
	IMU IMU Ann: Investor Presentation
	IMU IMU Ann: Investor Webinar Presentation Clarification
	IMU IMU Ann: Investor Webinar Presentation
	IMU IMU Ann: Imugene Appoints Dr Monil Shah as Chief Business Officer
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Change of Director's Interest Notice - LC
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Managing Director and CEO increases shareholding in Imugene
	IMU IMU Ann: Change of Director's Interest Notice - PH
	IMU IMU Ann: Change of Director's Interest Notice - LC
	IMU IMU Ann: Change of Director's Interest Notice - CW
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: CEO & Executive Chairman increases IMU shareholding
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Investor Webinar Details
	IMU IMU Ann: Investor Presentation
	IMU IMU Ann: IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Prestigious Research Journal Publish HER-Vaxx Phase 1B Data
	IMU IMU Ann: Appendix 4C - quarterly
	IMU IMU Ann: Imugene announces clinical milestone for HER-Vaxx
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: Imugene Oncolytic Virus Presentation at AACR 2021 Meeting
	IMU IMU Ann: Imugene HER-Vaxx Presentation at AACR 2021 Meeting
	IMU IMU Ann: Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: Proposed issue of Securities - IMU
	IMU IMU Ann: S&P DJI Announces March 2021 Quarterly Rebalance
	IMU IMU Ann: Appendix 3G
	IMU IMU Ann: Imugene to Present Oncolytic Virus Data at AACR21 Meeting

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
02-Jul	$0.44	1,529,528	+0.42 (3,246.15%)
30-Jun	$0.01	23,981,492	0.00 (0.00%)
27-Jun	$0.01	50,567,876	+0.00 (18.18%)
26-Jun	$0.01	30,696,793	0.00 (8.33%)
24-Jun	$0.01	11,610,882	0.00 (7.69%)
23-Jun	$0.01	14,420,312	0.00 (7.14%)
20-Jun	$0.01	20,575,964	+0.00 (7.69%)
19-Jun	$0.01	23,561,700	0.00 (0.00%)
18-Jun	$0.01	24,687,999	0.00 (13.33%)
16-Jun	$0.02	7,454,486	0.00 (0.00%)
13-Jun	$0.02	8,369,714	0.00 (0.00%)
12-Jun	$0.02	5,001,822	0.00 (6.25%)
06-Jun	$0.02	20,099,905	0.00 (0.00%)
05-Jun	$0.02	30,071,038	0.00 (0.00%)
04-Jun	$0.02	25,081,576	+0.00 (14.29%)
4 up, 5 down, and 6 flat days

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

Imugene Health Care
Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

$0.091 0.002 (2.25%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

$0.091 0.002 (2.25%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care
Cancer Health Care Immunotherapy